# The Global Fund Approves US$3.47 Million to Deliver Lifesaving TB and Malaria Services in Conflict-Affected Sudan

[download](/media/jh2jazxt/media_2026-10-23-global-fund-approves-usd3-47-million-lifesaving-tb-malaria-services-sudan_newsrelease_ar.pdf)

**GENEVA** – The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) has approved US$3.47 million in emergency funding to deliver essential tuberculosis (TB) and malaria diagnostics and medicines to eight Sudanese states severely affected by the ongoing conflict.

The funding builds on the [US$1.6 million](/en/news/2026/2026-03-27-global-fund-approves-emergency-tb-funding-sudan/ "2026-03-27 Global Fund Approves Emergency TB Funding Sudan") allocated through the Emergency Fund in March 2026, which supported the scale-up of TB diagnosis and treatment for internally displaced persons (IDPs) and host communities across 10 states.

These newly approved funds will be used to procure essential diagnostic tools and medicines to diagnose and treat people with malaria and TB in Darfur and Kordofan, which are among the regions most affected by conflict and violence. These include first- and second-line medicines for drug-resistant TB, laboratory diagnostics equipment, including 20 portable near-point-of-care testing machines for TB, as well as rapid diagnostic tests and medicines to diagnose and treat malaria. The United Nations Development Programme will serve as the implementing partner.

The crisis in Sudan remains one of the largest and most protracted humanitarian emergencies in the world. Since the armed conflict erupted in April 2023, Sudan has become the country with the largest internally displaced population in the world. Approximately 8.8 million people are currently displaced, and hundreds of health facilities have been destroyed, forced to close or rendered inaccessible, leaving millions without reliable access to essential health services.

Against this backdrop, disruptions to diagnosis and treatment can have devastating consequences. TB requires continuous treatment, while untreated malaria can rapidly become life-threatening, particularly for pregnant women and children.

Darfur and Kordofan are home to approximately 42% of Sudan’s population and two-thirds of its IDPs. The burden of TB and malaria has increased across the country since 2023, but reported cases in these regions have fallen sharply, raising concerns that thousands of infections may be going undetected and untreated.

These funds build on recent efforts to restore supply routes and re-establish essential TB and malaria services in hard-to-reach areas of Darfur and Kordofan, through the work of partners operating in these areas.

“This is exactly what the Emergency Fund was designed for,” said Mark Edington, Head of Grant Management at the Global Fund. “After years of conflict and disruption, we have a critical window of opportunity to reach communities that have been cut off from lifesaving healthcare. We must move swiftly to deliver essential medicines and diagnostics to those who need them most.”

Sudan’s crisis highlights the importance of sustaining essential health services in conflict-affected settings, where displacement, disrupted supply chains and weakened health systems leave communities increasingly vulnerable to preventable diseases. Maintaining access to lifesaving care in these environments is critical to protecting communities, preventing further loss of life and reducing the risk of disease outbreaks.

Between 2014 and October 2026, the Global Fund provided US$173.1 million through its Emergency Fund to support urgent responses to health crises in 39 countries, including Sudan. The Emergency Fund plays a critical role in enabling rapid responses to crises that threaten access to lifesaving HIV, TB and malaria services.